![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 44, 28610-28616, October 30, 1998
From the Department of Zoology, University of Oxford, South Parks
Road, Oxford OX1 3PS, United Kingdom
The soluble type 2 insulin-like growth factor
(IGF) receptor or IGF-II/mannose 6-phosphate receptor (sIGF2R) is
produced in vivo by proteolytic deletion of the
transmembrane and intracellular domains of the cellular form of the
receptor (IGF2R). There is evidence that sIGF2R is a negative regulator
of growth. We have shown that transgenic mice expressing an
Igf2r cDNA with a deleted transmembrane domain
sequence (s
The Soluble Type 2 Insulin-like Growth Factor (IGF-II) Receptor
Reduces Organ Size by IGF-II-mediated and IGF-II-independent
Mechanisms
Igf2r) show reduced local organ size.
In the present study, we investigate whether s
IGF2R can slow the
growth induced by an excess of IGF-II and whether the biological
activity of s
IGF2R is due solely to its interactions with IGF-II. To
this end, we crossed s
Igf2r transgenics by mice overexpressing IGF-II (Blast line) or by mice carrying a
disrupted paternal (active) allele of the Igf2 gene
(Igf2m+/p
). Analysis of the phenotypes
revealed that the soluble IGF2R affects the size of some organs (colon
and cecum) exclusively by reducing the biological activity of IGF-II,
whereas in other organs (stomach and skin) the biological activity of
the receptor is at least in part independent of IGF-II and must involve
an interaction with other factor(s).
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Heo, U. Jariwala, J. Woo, Y. Zhan, K. A. Burke, L. Zhu, W. F. Anderson, and Y. Zhao Involvement of Niemann-Pick Type C2 Protein in Hematopoiesis Regulation Stem Cells, June 1, 2006; 24(6): 1549 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, and C. Y. Bowers Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition Endocr. Rev., April 1, 2006; 27(2): 101 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Harper, J. L. Burns, E. J. Foulstone, M. Pignatelli, S. Zaina, and A. B. Hassan Soluble IGF2 Receptor Rescues ApcMin/+ Intestinal Adenoma Progression Induced by Igf2 Loss of Imprinting Cancer Res., February 15, 2006; 66(4): 1940 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Wise and D. D. Pravtcheva Delayed Onset of Igf2-Induced Mammary Tumors in Igf2r Transgenic Mice Cancer Res., February 1, 2006; 66(3): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Hassan Keys to the Hidden Treasures of the Mannose 6-Phosphate/Insulin-Like Growth Factor 2 Receptor Am. J. Pathol., January 1, 2003; 162(1): 3 - 6. [Full Text] [PDF] |
||||
![]() |
S. Garrone, G. Radetti, M. Sidoti, M. Bozzola, F. Minuto, and A. Barreca Increased Insulin-Like Growth Factor (IGF)-II and IGF/IGF-Binding Protein Ratio in Prepubertal Constitutionally Tall Children J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5455 - 5460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mills, N. Andersson, C. V. Hong, T. S. Stappenbeck, and J. I. Gordon Molecular characterization of mouse gastric epithelial progenitor cells PNAS, November 12, 2002; 99(23): 14819 - 14824. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zaina, L. Pettersson, B. Ahren, L. Branen, A. B. Hassan, M. Lindholm, R. Mattsson, J. Thyberg, and J. Nilsson Insulin-like Growth Factor II Plays a Central Role in Atherosclerosis in a Mouse Model J. Biol. Chem., February 1, 2002; 277(6): 4505 - 4511. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Burns and A. B. Hassan Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation Development, October 1, 2001; 128(19): 3819 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hill, B. Strutt, E. Arany, S. Zaina, S. Coukell, and C. F. Graham Increased and Persistent Circulating Insulin-Like Growth Factor II in Neonatal Transgenic Mice Suppresses Developmental Apoptosis in the Pancreatic Islets Endocrinology, March 1, 2000; 141(3): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Hassan and J. A. Howell Insulin-like Growth Factor II Supply Modifies Growth of Intestinal Adenoma in ApcMin/+ Mice Cancer Res., February 1, 2000; 60(4): 1070 - 1076. [Abstract] [Full Text] |
||||
![]() |
R.L. Gardner, S. Squire, S. Zaina, S. Hills, and C.F. Graham Insulin-Like Growth Factor-2 Regulation of Conceptus Composition: Effects of the Trophectoderm and Inner Cell Mass Genotypes in the Mouse Biol Reprod, January 1, 1999; 60(1): 190 - 195. [Abstract] [Full Text] |
||||
![]() |
J. Linnell, G. Groeger, and A. B. Hassan Real Time Kinetics of Insulin-like Growth Factor II (IGF-II) Interaction with the IGF-II/Mannose 6-Phosphate Receptor. THE EFFECTS OF DOMAIN 13 AND pH J. Biol. Chem., June 22, 2001; 276(26): 23986 - 23991. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |